The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Tamoxifen for the Prevention of Breast Cancer: Psychosocial Impact on Women Participating in Two Randomized Controlled Trials
Open accessAbstract
PURPOSE: The purpose of this study was to evaluate the psychosocial implications of tamoxifen versus placebo in women who are at increased risk of breast cancer. PATIENTS AND METHODS: The 488 women in the psychosocial study were recruited from participants in two placebo-controlled, double-blind, randomized, controlled trials that investigated the efficacy of tamoxifen in the prevention of breast cancer in women who are at high familial risk. During a 5-year period, repeated assessments were made of anxiety, psychological distress, and sexual functioning using standardized questionnaires before treatment at baseline and at 6-month intervals during the trial. RESULTS: Questionnaire completion over 5 years was good, with 71.1% of women returning at least 8 of 10 follow-up assessments. Although scores from individuals showed considerable fluctuation and variation over time, changes in anxiety, mood, and sexual functioning were not associated with treatment group. The number of symptoms reported at 48 months via a self-report cheklist were not associated with treatment group, but vasomotor symptoms were more frequent among tamoxifen-treated women. Symptoms of low energy, breast sensitivity, and visual blurring were reported most frequently in the placebo group. CONCLUSION: In general, these results are comparable to those from the National Surgical Adjuvant Breast and Bowel Project psychosocial study despite differences in study populations, methodology, and instruments. The long-term use of tamoxifen and other selective estrogen response modulators as preventive agents in high-risk groups has been questioned, but we found no evidence of treatment-related side effects that affect women’s psychosocial and sexual functioning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of the multidimensional health locus of control (MHLC) scales
Wallston, K. A., Strudler Wallston, B., & DeVellis, R. (1978) · Health Education Monographs · doi:10.1177/109019817800600107 · Cited by 3,373
Cited by
Prevalence of depression in patients with cancer
Massie, M. J. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh014 · Cited by 1,408
Quality of Life in Long-Term, Disease-Free Survivors of Breast Cancer: a Follow-up Study
Ganz, P. A. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.1.39 · Cited by 1,060
Breast Cancer in Younger Women: Reproductive and Late Health Effects of Treatment
Ganz, P. A., Greendale, G. A., Petersen, L., Kahn, B., & Bower, J. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.196 · Cited by 533
Stearns, V., Beebe, K. L., Iyengar, M., & Dube, E. (2003) · JAMA · doi:10.1001/jama.289.21.2827 · Cited by 496
Anxiety Disorders in Cancer Patients: Their Nature, Associations, and Relation to Quality of Life
Stark, D., Kiely, M., Smith, A., Velikova, G., House, A., & Selby, P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.549 · Cited by 496
Metadata
- Authors
- Fallowfield, L., Fleissig, A., Edwards, R., West, A., Powles, T. J., Howell, A., & Cuzick, J.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-04-01
- Volume
- 19
- Issue
- 7
- Pages
- 1885-1892
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1846149924
- Cited by
- 166
- References
- 1
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tamoxifen for the Prevention of Breast Cancer: Psychosocial Impact on Women Participating in Two Randomized Controlled Trials. https://app.cochat.ai/papers/10.1200/jco.2001.19.7.1885
- The paper
- Fallowfield, L., Fleissig, A., Edwards, R., West, A., Powles, T. J., Howell, A., & Cuzick, J. (2001). Tamoxifen for the Prevention of Breast Cancer: Psychosocial Impact on Women Participating in Two Randomized Controlled Trials. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2001.19.7.1885
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.